Cargando…
The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions
Host-microbiota interactions involving inflammatory and metabolic pathways have been linked to the pathogenesis of multiple immune-mediated diseases and metabolic conditions like diabetes and obesity. Accumulating evidence suggests that alterations in the gut microbiome could play a role in cardiova...
Autores principales: | Trøseid, Marius, Andersen, Geir Øystein, Broch, Kaspar, Hov, Johannes Roksund |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016372/ https://www.ncbi.nlm.nih.gov/pubmed/32062353 http://dx.doi.org/10.1016/j.ebiom.2020.102649 |
Ejemplares similares
-
Reply: Potential risk associated with direct modulation of the gut flora in patients with heart failure
por: Mayerhofer, Cristiane C.K., et al.
Publicado: (2019) -
Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure
por: Nendl, Andraž, et al.
Publicado: (2023) -
Design of the GutHeart—targeting gut microbiota to treat heart failure—trial: a Phase II, randomized clinical trial
por: Mayerhofer, Cristiane C.K., et al.
Publicado: (2018) -
Low fibre intake is associated with gut microbiota alterations in chronic heart failure
por: Mayerhofer, Cristiane C.K., et al.
Publicado: (2020) -
Rosuvastatin alters the genetic composition of the human gut microbiome
por: Kummen, Martin, et al.
Publicado: (2020)